The Interplay of Inherited Chromosomally Integrated Human Herpesvirus 6, Telomere Length, and the Metabolome in Autoimmune Disease Incidence: Evidence from the UK Biobank Study

Authors:

Abstract
Autoimmune diseases arise from failures in immune regulation and increase with biological aging. Inherited chromosomally integrated human herpesvirus-6 (iciHHV-6) represents a unique model of lifelong viral exposure, as the viral genome is embedded within host telomeres and may influence leukocyte telomere length (LTL), a marker of immune aging. Circulating metabolites may further shape these viral-telomeric interactions. Using 156,927 UK Biobank participants free of autoimmune disease at baseline, we examined associations between iciHHV-6, LTL, and incident autoimmune disease, and evaluated metabolomic pathways that mediate or modify these relationships. Over follow-up, autoimmune disease incidence was 7.8%, and iciHHV-6 prevalence was 1.3%. iciHHV-6 carrier status was not directly associated with autoimmune disease risk despite higher comorbidity burden. Longer LTL was independently protective overall, particularly for rheumatoid arthritis, although it was positively associated with multiple sclerosis. iciHHV-6 carriers exhibited longer LTL, resulting in a small but significant indirect protective effect on autoimmune disease risk. LTL also moderated viral effects, with stronger protection among iciHHV-6-positive individuals, suggesting telomere length buffers adverse viral-immune interactions. Metabolomic analyses revealed that triglyceride-rich lipoproteins and pro-inflammatory lipids were associated with shorter LTL and higher autoimmune risk, whereas omega-3 fatty acids, albumin, and HDL phospholipids were protective. Lipidomic pathways mediated a meaningful proportion of the LTL-autoimmune association and modified viral effects. Together, these findings support a telomere-lipid-immunity axis linking viral integration, metabolic aging, and autoimmune susceptibility.